Mukosat-Belmed capsules 250mg №10×3

Name Mukosat-Belmed caps. Main active ingredientChondroitin sulfate Release formCapsules Dosage250mg Pharmacological actionChondroitin sulfate ? mucopolysaccharide and one of the components of cartilage. It has a high ability to bind water, thus it provides the mechanical and elastic properties of the cartilage. With degenerative processes in the joints, a decrease in the reserves of chondroitin sulfate in cartilage tissue is observed, caused by specific lytic enzymes. As a result of the loss of the ability to bind water, deterioration in cartilage degeneration and joint function progresses. Chondroitin sulfate inhibits cartilage-degrading elastase in vitro. The use of exogenous administration of chondroitin sulfate leads to the restoration of metabolic balance. Clinical efficacy Clinical studies have shown that the use of chondroitin eliminates or reduces pain and, in most cases, improves joint mobility. Indications for use Symptomatic therapy to reduce pain in degenerative-dystrophic diseases of the hip and knee joints? as part of complex therapy. Dosage and administration Inside: adults: 2 capsules (2-250 mg) 2 times a day (daily dose 1000 mg). Capsules are taken with a small amount of water. The duration of the course of treatment is 4-5 weeks. Repeat course? in 6 months. Application during pregnancy and lactation Use during pregnancy and lactation is contraindicated (for the duration of treatment, breastfeeding should be stopped). Influence on the ability to drive vehicles and other potentially dangerous mechanisms Does not affect the ability to drive a vehicle or potentially dangerous mechanisms. Precautions The clinical effect when taking the drug comes slowly, but persists for a long time for several months after the end of the course of treatment. To prevent exacerbations, repeated courses of treatment are indicated. In case of allergic reactions, treatment should be discontinued. Interaction with other drugs While taking Mucosat-Belmed capsules, the need for the use of non-steroidal anti-inflammatory drugs may decrease. It is possible to enhance the action of indirect anticoagulants, antiplatelet agents, fibrinolytics. Contraindications Hypersensitivity, tendency to bleeding, thrombophlebitis, pregnancy, lactation (for the duration of treatment, breastfeeding should be stopped); children’s age up to 18 years. Composition Each capsule contains: active substance: chondroitin sulfate sodium ? 250 mg; excipients: calcium stearate, potato starch. The composition of the hard gelatin capsule: gelatin, glycerin, purified water, titanium dioxide, sodium lauryl sulfate. Overdose So far, no cases of overdose have been reported. Side effects Allergic reactions. In the event of adverse reactions, incl. not listed in this leaflet for medical use of the drug, you should consult a doctor. Storage conditions In a place protected from moisture and light at a temperature not exceeding 25 ° C. Keep out of the reach of children. Buy Mukosat-Belmed capsules 250mg No. 10×3 Price for Mukosat-Belmed capsules 250mg No. 10×3